Telmisartan protects chronic intermittent hypoxic mice via modulating cardiac renin-angiotensin system activity

Abstract Background To explore the effects of chronic intermittent hypoxia (CIH), which mimics sleep apnea syndrome, on the cardiac renin angiotensin system (RAS), and to investigate the cardiac protection of an angiotensin receptor blocker (ARB)telmisartan (TERT) against CIH. Methods 32 healthy mal...

Full description

Bibliographic Details
Main Authors: Wanyu Wang, Ailing Song, Yiming Zeng, Xiaoyang Chen, Yixiang Zhang, Yonghong Shi, Yihua Lin, Wen Luo
Format: Article
Language:English
Published: BMC 2018-07-01
Series:BMC Cardiovascular Disorders
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12872-018-0875-4
_version_ 1818341557356462080
author Wanyu Wang
Ailing Song
Yiming Zeng
Xiaoyang Chen
Yixiang Zhang
Yonghong Shi
Yihua Lin
Wen Luo
author_facet Wanyu Wang
Ailing Song
Yiming Zeng
Xiaoyang Chen
Yixiang Zhang
Yonghong Shi
Yihua Lin
Wen Luo
author_sort Wanyu Wang
collection DOAJ
description Abstract Background To explore the effects of chronic intermittent hypoxia (CIH), which mimics sleep apnea syndrome, on the cardiac renin angiotensin system (RAS), and to investigate the cardiac protection of an angiotensin receptor blocker (ARB)telmisartan (TERT) against CIH. Methods 32 healthy male C57B6J mice were randomly divided into CIH, ARB, blank and air control groups. CIH lasted for 12 weeks. Cardiac angiotensin converting enzyme (ACE), angiotensin converting enzyme 2 (ACE 2) and angiotensin II (Ang II) were evaluated by immunohistochemistry. Myocardial apoptosis were assessed by TUNEL assay and myocardial cell ultrastructure were observed under transmission electron microscope. Results Cardiac ACE expression was higher in the CIH group than in blank and air control groups, which was decreased with TERT treatment. TERT treatment elevated the expression of cardiac ACE 2 and Ang II compared with CIH group. Myocardial cell and capillary endothelial cell apoptosis, mitochondrial injury were most severe in CIH groups, which were mitigated with TERT treatment. Conclusions CIH changes the expression of cardiac ACE, ACE2 and Ang II, which may cause myocardial damage. TERT protects mice from CIH-linked cardiac damage via modulating the activity of RAS in the hearts.
first_indexed 2024-12-13T16:00:41Z
format Article
id doaj.art-e431787a0d5049099df8463bc5673224
institution Directory Open Access Journal
issn 1471-2261
language English
last_indexed 2024-12-13T16:00:41Z
publishDate 2018-07-01
publisher BMC
record_format Article
series BMC Cardiovascular Disorders
spelling doaj.art-e431787a0d5049099df8463bc56732242022-12-21T23:39:11ZengBMCBMC Cardiovascular Disorders1471-22612018-07-011811910.1186/s12872-018-0875-4Telmisartan protects chronic intermittent hypoxic mice via modulating cardiac renin-angiotensin system activityWanyu Wang0Ailing Song1Yiming Zeng2Xiaoyang Chen3Yixiang Zhang4Yonghong Shi5Yihua Lin6Wen Luo7Pneumology Department of the First Affiliated Hospital of XiaMen University, The first clinical medical college of Fujian Medical University Teaching hospital of Fujian Medical UniversityPneumology Department of Wuxi Branch of Rijin Hospital affiliated to Shanghai jiaotong university medical collegeDepartment of Pulmonary and Critical Care Medicine of the Second Affiliated Hospital of Fujian Medical University, Sleep and Breathing Disorders Research Institute of Fujian Medical UniversityDepartment of Pulmonary and Critical Care Medicine of the Second Affiliated Hospital of Fujian Medical University, Sleep and Breathing Disorders Research Institute of Fujian Medical UniversityDepartment of Pulmonary and Critical Care Medicine of the Second Affiliated Hospital of Fujian Medical University, Sleep and Breathing Disorders Research Institute of Fujian Medical UniversityPneumology Department of the First Affiliated Hospital of XiaMen University, The first clinical medical college of Fujian Medical University Teaching hospital of Fujian Medical UniversityPneumology Department of the First Affiliated Hospital of XiaMen University, The first clinical medical college of Fujian Medical University Teaching hospital of Fujian Medical UniversityPneumology Department of the First Affiliated Hospital of XiaMen University, The first clinical medical college of Fujian Medical University Teaching hospital of Fujian Medical UniversityAbstract Background To explore the effects of chronic intermittent hypoxia (CIH), which mimics sleep apnea syndrome, on the cardiac renin angiotensin system (RAS), and to investigate the cardiac protection of an angiotensin receptor blocker (ARB)telmisartan (TERT) against CIH. Methods 32 healthy male C57B6J mice were randomly divided into CIH, ARB, blank and air control groups. CIH lasted for 12 weeks. Cardiac angiotensin converting enzyme (ACE), angiotensin converting enzyme 2 (ACE 2) and angiotensin II (Ang II) were evaluated by immunohistochemistry. Myocardial apoptosis were assessed by TUNEL assay and myocardial cell ultrastructure were observed under transmission electron microscope. Results Cardiac ACE expression was higher in the CIH group than in blank and air control groups, which was decreased with TERT treatment. TERT treatment elevated the expression of cardiac ACE 2 and Ang II compared with CIH group. Myocardial cell and capillary endothelial cell apoptosis, mitochondrial injury were most severe in CIH groups, which were mitigated with TERT treatment. Conclusions CIH changes the expression of cardiac ACE, ACE2 and Ang II, which may cause myocardial damage. TERT protects mice from CIH-linked cardiac damage via modulating the activity of RAS in the hearts.http://link.springer.com/article/10.1186/s12872-018-0875-4Chronic intermittent hypoxiaSleep apnea syndromesTelmisartinACEACE 2Ang II
spellingShingle Wanyu Wang
Ailing Song
Yiming Zeng
Xiaoyang Chen
Yixiang Zhang
Yonghong Shi
Yihua Lin
Wen Luo
Telmisartan protects chronic intermittent hypoxic mice via modulating cardiac renin-angiotensin system activity
BMC Cardiovascular Disorders
Chronic intermittent hypoxia
Sleep apnea syndromes
Telmisartin
ACE
ACE 2
Ang II
title Telmisartan protects chronic intermittent hypoxic mice via modulating cardiac renin-angiotensin system activity
title_full Telmisartan protects chronic intermittent hypoxic mice via modulating cardiac renin-angiotensin system activity
title_fullStr Telmisartan protects chronic intermittent hypoxic mice via modulating cardiac renin-angiotensin system activity
title_full_unstemmed Telmisartan protects chronic intermittent hypoxic mice via modulating cardiac renin-angiotensin system activity
title_short Telmisartan protects chronic intermittent hypoxic mice via modulating cardiac renin-angiotensin system activity
title_sort telmisartan protects chronic intermittent hypoxic mice via modulating cardiac renin angiotensin system activity
topic Chronic intermittent hypoxia
Sleep apnea syndromes
Telmisartin
ACE
ACE 2
Ang II
url http://link.springer.com/article/10.1186/s12872-018-0875-4
work_keys_str_mv AT wanyuwang telmisartanprotectschronicintermittenthypoxicmiceviamodulatingcardiacreninangiotensinsystemactivity
AT ailingsong telmisartanprotectschronicintermittenthypoxicmiceviamodulatingcardiacreninangiotensinsystemactivity
AT yimingzeng telmisartanprotectschronicintermittenthypoxicmiceviamodulatingcardiacreninangiotensinsystemactivity
AT xiaoyangchen telmisartanprotectschronicintermittenthypoxicmiceviamodulatingcardiacreninangiotensinsystemactivity
AT yixiangzhang telmisartanprotectschronicintermittenthypoxicmiceviamodulatingcardiacreninangiotensinsystemactivity
AT yonghongshi telmisartanprotectschronicintermittenthypoxicmiceviamodulatingcardiacreninangiotensinsystemactivity
AT yihualin telmisartanprotectschronicintermittenthypoxicmiceviamodulatingcardiacreninangiotensinsystemactivity
AT wenluo telmisartanprotectschronicintermittenthypoxicmiceviamodulatingcardiacreninangiotensinsystemactivity